Post-traumatic Aspergillus niger empyema in an immunocompetent military patient: a case report Authors: Dan Levy Faber, Sonia Schneer, Ronen Galili, Abed Agbarya Published: 2026 ABSTRACT BackgroundFungal empyema is an uncommon clinical entity, and empyema attributable to Aspergillus species is exceedingly rare. The vast majority of reported cases occur in immunocompromised hosts. Empyema caused specifically by Aspergillus niger has been described only in exceptional circumstances and is virtually absent from the medical literature. We report the first documented case of post-traumatic Aspergillus niger empyema in a young, immunocompetent individual.Case presentationA 22-year-old male active-duty special forces soldier sustained a penetrating gunshot wound to the left thorax during combat. Initial management included bilateral chest drain insertion and mechanical ventilation. He was discharged after eight days in satisfactory condition. Over the subsequent months, he developed progressive pleuritic chest pain and exercise intolerance. Chest radiography first demonstrated a small right pleural effusion, and computed tomography (CT) performed eight months post-injury subsequently revealed a complex, loculated right pleural collection. Thoracoscopic exploration identified a dense inflammatory process with an encased lung beneath a thick fibrinous peel. Decortication was performed and microbiological cultures—including fungal cultures, obtained due to the atypical clinical course—were positive for Aspergillus niger in both the pleural fluid and pleural tissue. No other pathogen was identified. Histopathology as an evidence of tissue invasion by septate hyphae, was not obtained. The patient completed a six-month course of voriconazole (300 mg twice daily) with good tolerability and a favourable clinical outcome.ConclusionsThis case highlights the importance of maintaining a broad microbiological differential—including uncommon fungal pathogens—in post-traumatic pleural space infections with atypical or indolent presentations, even in immunocompetent patients. Early surgical intervention and targeted antifungal therapy are key to achieving a successful outcome.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1186/s12879-026-14125-5. Background Aspergillus is an airborne saprophytic fungus encompassing more than 800 species. The genus was first described in the seventeenth century by the Italian botanist Pier Antonio Micheli, who named it in reference to the aspergillum—a liturgical holy water sprinkler—on account of the characteristic spore-bearing morphology [1]. The organism is ubiquitous in the environment, being recoverable from soil, water, air, and decaying organic matter. The clinical behaviour of Aspergillus infection is determined by a complex interplay between fungal burden, species virulence, and the immunological status of the host [2, 3]. The clinical spectrum of aspergillosis ranges from non-invasive manifestations—such as allergic bronchopulmonary aspergillosis—to life-threatening invasive pulmonary aspergillosis. Whereas the lungs represent the most frequently affected organ, virtually any organ system may be involved. Immunocompromised individuals, particularly those with prolonged granulocytopenia following cytotoxic chemotherapy, carry the highest risk for invasive disease [4]. Fungal empyema thoracis is a rare clinical entity. Candida species constitute the most commonly implicated pathogens, followed, at considerably lower frequency, by Aspergillus species [5]. Aspergillus niger, the causative organism in the present case, is not considered a major human pathogen under most circumstances and has received comparatively little attention in the infectious disease’s literature. Case presentation A 22-year-old male, healthy with no medical history, serving as a special forces soldier sustained a penetrating gunshot wound to the left thorax during active combat operations. The bullet entered above the left clavicular region, superior to the patient’s ceramic body armour, and exited posteriorly between the fourth and fifth ribs, medial to the scapula, (Fig. 1a). Field resuscitation was performed by unit medical personnel, and the patient was evacuated by air medical transport to a level-one trauma centre. On first medical contact the patient was defined as hemodynamically unstable due to the combination of altered states of consciousness and penetration gunshot injury to the left chest. Since the event was during active combat no medical record or physiological parameters were taken. Bilateral chest drains were rapidly inserted in the field on the basis of penetrating left thoracic trauma and loss of consciousness which imply to hemodynamic compromise. Mechanical ventilation was initiated. Upon arrival at the trauma center first laboratory values were: Blood pH 7.33, pO2 46.8mmHg, pO2 4836 mmHg, HCO3 24.2 mmol/L, hemoglobin 10gr/dl, white cell counts 14,700/ul with NEUT 71%, platelet count 163,000/ul. Coagulation profile INR 1.11, PT 12.8 s, fibrinogen 322 mg/dl. Due to his status the patient received only two units of packed red blood cells as part of haemostatic resuscitation and underwent contrast-enhanced computed tomography (CT) of the thorax. Imaging revealed: a traumatic penetrating injury predominantly affecting the left upper lobe; a moderate left haemopneumothorax; posterior rib fractures of the fourth and fifth ribs at the exit wound site; a small right pneumothorax; and bilateral pleural drains in situ. Empirical peri-traumatic antimicrobial prophylaxis was administered in accordance with institutional protocol for penetrating thoracic trauma cefuroxime 750 mg x3/day and Metronidazole 500mh x 3/day for 5 days. The patient was managed conservatively, was successfully weaned from mechanical ventilation on post-injury day two. RT chest drain was removed in post injury day two and LT chest drain was removed in post injury day five the patient was discharged home in overall satisfactory physical condition on post-injury day eight. During the initial three months of follow-up, the patient demonstrated a favourable rehabilitation trajectory, with progressive healing of both internal and external injuries. In the ensuing months, however, he began experiencing pleuritic chest pain, particularly on exertion, accompanied by an inability to recover his pre-injury level of physical conditioning. A chest radiograph obtained at this stage disclosed a small right pleural effusion. Several courses of non-steroidal anti-inflammatory drugs were prescribed, yielding transient symptomatic relief; however, given the persistence of symptoms, the patient was referred to our department for further evaluation. At assessment, eight months after the initial injury, the pleural effusion appeared to have increased in volume. Repeat thoracic CT demonstrated evidence of healed left lung injury and a small, complex, loculated pleural collection confined to the right pleural base, (Fig. 1b). The decision was made to proceed with right-sided thoracoscopic exploration. Intraoperative findings were notable for a dense inflammatory reaction with marked lung entrapment beneath a thick fibrinous peel. Meticulous video-assisted thoracoscopic decortication was performed, with removal of all pleural debris and restoration of full lung re-expansion. Microbiological specimens were obtained from the pleural fluid and pleural tissue; given the atypical clinical course and complex traumatic circumstances, specimens were explicitly submitted for fungal culture in addition to standard bacteriological workup. The patient was discharged on post-operative day four in satisfactory condition. All cultures were positive for Aspergillus niger in both the pleural fluid and pleural tissue samples, with no other infectious agent identified. The organism was identified on the basis of microscopic morphology and the use of MALDI-TOF mass spectrometry and Lactophenol Blue stain. A comprehensive workup for immunodeficiency status was carried out and revealed negative results for immunodeficiency status. This workup included: HIV serology, fasting glucose and/or HbA1c, full blood count with absolute neutrophil and lymphocyte counts, serum immunoglobulins, nutritional status, and corticosteroid/immunosuppressant history Antifungal therapy was initiated with voriconazole 200 mg twice daily but due to low level of the drug on blood test we gradually increased the voriconazole to 300 mg twice daily reaching therapeutic level of the drug on blood test. Voriconazole was administered for a total duration of six months The prolonged six-month course was selected in view of the loculated, organised pleural process with lung entrapment and the rarity of the pathogen, rather than the six-week course typical of uncomplicated bacterial empyema. Tolerability was good and the patient achieved a favorable overall clinical outcome. Table 1. Describes the clinical timeline of this case report. Table 1Timeline of key events from injury to final follow-upTime pointEventDay 0 (injury)Penetrating left thoracic gunshot wound; field resuscitation; bilateral field chest drains; mechanical ventilationDay 0–2Trauma-center CT; two units packed red cells; peri-traumatic antibiotic prophylaxis; weaned from ventilation on day 2.Chest drains [Note to author: insert dwell time and removal day]Duration and management of thoracostomy tubes; output volume and character.Day 8Discharge in satisfactory condition.~ 3 monthsOnset of exertional pleuritic chest pain; chest radiograph showing small right pleural effusion; NSAID courses with transient relief.8 monthsRepeat CT: complex loculated right pleural collection. Right VATS decortication; pleural fluid and tissue submitted for bacterial and fungal culture and histopathology. Discharge on post-operative day 4.Post-operativeCultures positive for Aspergillus niger (fluid and tissue); voriconazole commenced.Through ~ 14 monthsSix-month course of voriconazole; favourable outcome. Table 1Timeline of key events from injury to final follow-upTime pointEventDay 0 (injury)Penetrating left thoracic gunshot wound; field resuscitation; bilateral field chest drains; mechanical ventilationDay 0–2Trauma-center CT; two units packed red cells; peri-traumatic antibiotic prophylaxis; weaned from ventilation on day 2.Chest drains [Note to author: insert dwell time and removal day]Duration and management of thoracostomy tubes; output volume and character.Day 8Discharge in satisfactory condition.~ 3 monthsOnset of exertional pleuritic chest pain; chest radiograph showing small right pleural effusion; NSAID courses with transient relief.8 monthsRepeat CT: complex loculated right pleural collection. Right VATS decortication; pleural fluid and tissue submitted for bacterial and fungal culture and histopathology. Discharge on post-operative day 4.Post-operativeCultures positive for Aspergillus niger (fluid and tissue); voriconazole commenced.Through ~ 14 monthsSix-month course of voriconazole; favourable outcome. Timeline of key events from injury to final follow-up Fig. 1a. Thoracic CT at two- and eight-months post-injury demonstrating the gunshot wound healing in left lung. b. Thoracic CT at two- and eight-months post-injury demonstrating the development of a complex, loculated right pleural collection a. Thoracic CT at two- and eight-months post-injury demonstrating the gunshot wound healing in left lung. b. Thoracic CT at two- and eight-months post-injury demonstrating the development of a complex, loculated right pleural collection Discussion Aspergillus empyema typically arises as a complication of antecedent pleural or pulmonary pathology, including prior infectious processes (e.g., tuberculosis, staphylococcal pneumonia), invasive procedures (e.g., pulmonary resection, pleural drainage), or thoracic structural abnormalities such as bronchopleural fistulae [3, 6–8]. In contrast to invasive pulmonary aspergillosis, Aspergillus empyema has been documented in immunocompetent patients, albeit rarely [9, 10]. Chang et al. conducted a systematic review of Aspergillus empyema cases reported over a ten-year period (2012–2022) and identified twenty-one published cases [1]. Of these, only five had histopathological confirmation of invasive fungal disease. The majority of patients had identifiable predisposing conditions or some degree of immunosuppression; only two patients presented without any demonstrable risk factors. In nearly all cases, a plausible aetiology for empyema development was apparent—none of which involved traumatic injury, in contrast to the present case. With one exception, all patients were managed with surgical intervention combined with systemic antifungal therapy; in four cases, direct intrapleural antifungal instillation was employed as an adjunct. Aspergillus fumigatus was the causative species in the substantial majority of reported cases (17 of 21 patients). Aspergillus niger—the pathogen identified in the present case—is not regarded as a major human pathogen in comparison with other Aspergillus species [11]. The organism is well-established in industrial applications, having been exploited as a source of citric acid and a range of industrially relevant enzymes for several decades. In nature, it proliferates on organic substrates, compost, and decomposing plant material. While A. niger is generally classified as safe, certain strains possess the capacity to elaborate ochratoxin A—a mycotoxin with established nephrotoxic and potentially carcinogenic properties—which may underlie the occasional occurrence of clinically significant infection in susceptible individuals [12]. In the present case, the indolent and atypical progression of post-traumatic pleuropulmonary disease prompted diagnostic surgical intervention. The extreme environmental conditions and complexity of the combat-related injury raised the clinical suspicion for an uncommon pathogen, which informed the decision to submit an extensive panel of microbiological specimens—including dedicated fungal cultures—at the time of surgery. The isolation of A. niger from both the pleural fluid and pleural tissue constitutes supportive microbiological evidence for this rare infection, the diagnostic weight of which is strengthened by recovery of the same organism from two separate specimen types rather than a single fluid sample in the context of the overall clinical picture. To the best of our knowledge, this is the first reported case of traumatic injury leading to fungal empyema caused by Aspergillus niger in the medical literature. A notable feature of this case is the apparent discordance between the side of injury and the side of infection. The penetrating wound, the left upper lobe parenchymal injury, the haemopneumothorax and the rib fractures were all left-sided, whereas the empyema and the subsequent decortication were right-sided. This discordance requires explanation, because it bears directly on the claim that the infection was post-traumatic in origin. The imaging obtained on admission documented a small right pneumothorax and bilateral pleural drains placed in the field. We propose that the right-sided field thoracostomy is the most plausible route of fungal inoculation: chest drains inserted under austere, non-sterile combat conditions provide a direct conduit from the contaminated external environment into the pleural space, and the right pleural cavity had no intrinsic parenchymal injury that would otherwise account for a localised collection. Competing explanations for a chronic right pleural collection following thoracic trauma warrant consideration. A retained or clotted haemothorax may organise and evolve into a fibrothorax or secondary empyema, and a residual post-traumatic effusion or a drain-associated bacterial empyema could produce a similar indolent course. These alternatives were addressed by the intraoperative and microbiological findings: a single organism, A. niger, was recovered from both pleural fluid and pleural tissue, no bacterial pathogen was isolated, and the operative specimen demonstrated an organised fibrinous peel consistent with a chronic infective process rather than uncomplicated blood. The diagnostic certainty of invasive fungal disease in this case merits a measured interpretation Aspergillus niger is ubiquitous in the environment and is a recognised laboratory and airway contaminant; positive culture alone does not distinguish invasive infection from colonization or specimen contamination. Definitive demonstration of invasive disease rests on histopathological identification of septate hyphae invading tissue. In the present report the recovery of a single organism from both fluid and solid tissue, in the setting of an organised pleural process and the absence of an alternative pathogen, favours true infection; however, in the absence of confirmed tissue invasion the certainty of the diagnosis should be regarded as moderate rather than definitive. Limitations. This report describes a single case, which constrains generalisability. Invasive fungal disease was not confirmed by histopathological demonstration of tissue invasion, so colonisation and contamination cannot be excluded with certainty. The designation of immunocompetence rests on the available clinical assessment, and any elements of the immunological workup that were not performed limit the strength of that characterisation. The proposed mechanism of inoculation via field thoracostomy is inferential and is not supported by direct microbiological sampling of the drains. Conclusions This case underscores the necessity of maintaining a broad differential diagnosis—inclusive of uncommon fungal pathogens such as Aspergillus niger—when evaluating pleural space infections with an atypical, indolent, or post-traumatic clinical course, even in the absence of classical immunosuppression. The complexity of the injury milieu and the absence of an alternative explanation should prompt comprehensive microbiological sampling, including fungal cultures. Where feasible, histopathological examination of pleural tissue should accompany culture to distinguish invasive infection from colonisation or contamination. Combined surgical decortication and prolonged antifungal therapy with voriconazole represent an effective management strategy. Heightened awareness of this rare entity may contribute to earlier diagnosis and improved clinical outcomes in future cases. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 1